Crouse Hospital
Syracuse, New York, 13210, United States
NCT Number: NCT00920062
This study is to test the usefulness of ultrasound dilution recirculation measurements in patients receiving venovenous extracorporeal membrane oxygenation as therapy. The ultrasound dilution measurements determine the efficiency of support provided by venovenous extracorporeal membrane oxygenation. At the present time there are no other devices available to make recirculation measurements.
Looking for future studies?
Notify MeUp to 21 year
All sexes
Observational
Syracuse, New York, 13210, United States
At the present time there are no devices available to measure recirculation in patients on venovenous extracorporeal membrane oxygenation. The study uses an external monitor, laptop computer, clamp on flowsensors and ultrasound dilution technology to measure blood flow. Measurements are made by injecting 0.5 - 1 ml/kg of sterile isotonic saline into the patient's extracorporeal circuit. The subject will be monitored throughout the measurements. The measurements will be coordinated with the regular care of the patient and their extracorporeal circuit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Duration of venovenous extracorporeal membrane oxygenation
Transonic Systems Inc.
Industry
Ultrasound Dilution Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05342363
Cardiovascular Resuscitation, Venovenous Extracorporeal Membrane Oxygenation
Frankfurt am Main, Hesse, Germany
View Trial Details